The medical technology company Zenicor reports both increased revenue and operating profit for the second quarter compared with the same period the previous year.Revenue rose 5.7 percent to SEK 7.4 million (7.0)."The growth during the quarter comes both from new customers and new agreements, as well as from our existing customers and license agreements. We have high usage and receive a lot of positive feedback from our existing customers," comments CEO Mats Palerius.Ebitda amounted to SEK 1.6 million (1.2), with an Ebitda margin of 21.6 percent (17.1). Operating profit amounted to SEK 0.5 million (0.1), with an operating margin of 6.8 percent (1.4). Profit after tax amounted to SEK 0.1 million (-0.1). Cash flow from operating activities amounted to SEK -0.7 million (-2.8).Zenicor, SEK millionQ2-2026Q2-2025ChangeNet sales7.47.05.7%Ebitda1.61.233.3%Ebitda margin21.6%17.1%Operating profit0.50.1400.0%Operating margin6.8%1.4%Net profit0.1-0.1Cash flow from operating activities-0.7-2.8